Page results
-
The UCLH trauma and orthopaedics team has reached a milestone of 1000 operations on hips and knees using the Mako robot.
-
October is free wills month. We have partnered with Octopus Legacy and are pleased to offer a free will writing service to all our supporters.
-
Professor Karl Peggs has been appointed as UCLH director of research and director of the National Institute for Health and Care Research (NIHR) UCLH Biomedical Research Centre (BRC).
-
3000 participants have been recruited to a clinical trial led by UCL and UCLH aimed at reducing the number of patients with breast cancer who are given chemotherapy unnecessarily.
-
UCLH doctor 1 of 10 international members elected to National Academy of Medicine
-
A new specialist blood transfusion service at Luton and Dunstable University Hospital is transforming care for people living with sickle cell disease (SCD) across the East of England.
-
Once again, UCLH has received the highest score of all general acute and acute/community NHS trusts in England for staff that would recommend us as a place to work
-
Mark Emberton joined the board as a non-executive director on 1 September 2022. He is Professor of Intervention Oncology within the Division of Surgery and Dean of the Faculty of Medical Science at University College London.
-
UCLH and Whittington Health have a long history of working together to benefit patients, staff and our communities across Camden, Haringey, Islington and beyond. This includes services such as the virtual ward, orthopaedic surgery and paediatric dentistry.
-
UCLH is committed to not only treat patients’ illnesses but to provide an environment and an experience which contributes to patients’ general wellbeing.
File results
-
FOI/2024/0092 - Decision to cease Salvage RARP with nerve spare in 2023
-
FOI/2024/0095 - Hospital at home - Discharge and discharge to assess pathways
-
FOI/2024/0097 - Laboratory Information Management System (LIMS)/ pathology IT system
-
FOI/2024/0116 - Patient treatment due to noise levels of the London Underground
-
FOI/2024/0131 - Alpha-1 Proteinase-Inhibitor (AAT) purchased in 2023
-
FOI/2024/0140 - Operations cancelled due to low levels of staffing 2019-2023
-
FOI/2024/0147 - Permits to Work
-
FOI/2024/0151 - A&E decision-to-admit wait times 2019-2023
-
FOI/2024/0158 - Procedures cancelled due to issues with defective diagnostic equipment
-
FOI/2024/0169 - Medical emergency protocols